Richard J. Turner

Transcriptogen Ltd. operates as a drug discovery company to exploit the use of small molecules to inhibit the interaction of transcription factors (TFs) with their cognate DNA-recognition site, thus down-regulating or inhibiting the transcription of disease-related genes. The firm develops and discovers anti-cancer drugs. The company was founded by Khondaker Miraz Rahman, Paul Jackson, and Sheraz Gul and is headquartered in Bath, the United Kingdom.

Catalyst Venture Partners Ltd. (CVP) is a London-based independent corporate finance advisory and private equity partnership established in 1999 by a group of technology entrepreneurs. Catalyst Venture Partners Ltd.